Skip to content

Screener

Eligibility screening

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalatio…

Sponsored by Regeneron PharmaceuticalsStudy detailsClinicalTrials.gov

55 US sites in CA, CO, FL, ID +19

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.